跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Febuxipro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Febuxipro
Approved
STANDARD
Febuxipro
Innova Captab Ltd. (Unit II)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1947dbcd9fc42e9f
Company
Innova Captab Ltd. (Unit II)
Type
Standard
Approval Details
Approval Id
1947dbcd9fc42e9f
Drug Approval Philippines Name
Febuxipro
Product Name
Febuxipro
Registration Number
DRP-14531-02
Brand Name
Febuxipro
Generic Name
Febuxostat
Dosage Form
Film-Coated Tablet
Dosage Strength
80 mg
Manufacturer
Innova Captab Ltd. (Unit II)
Importer
Ambica International Corporation
Distributor
AGB Pharmaceutical Trading and Consultancy Corporation
Issuance Date
25 July 2024
Expiry Date
03 October 2028
Pharmacologic Category
Anti-gout (Preparation Inhibiting Uric Acid Production)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1947dbcd9fc42e9f
Type
Standard
Back to Philippines FDA Approvals